InequalityOpen ScienceBig PharmaCOVID VaccinesDrug PatentsEconomics and BusinessThe Quant Case for Open-Access COVID Vaccineshttps://doi.org/10.59350/p8t30-2rw41Published June 9, 2021Author Blair FixExportCitationI crunch the numbers on COVID vaccines. No surprises … they’re going overwhelmingly to rich countries.